Legend Biotech Co. Forecasted to Earn Q1 2025 Earnings of ($0.30) Per Share (NASDAQ:LEGN)

Legend Biotech Co. (NASDAQ:LEGN – Free Report) – Analysts at William Blair issued their Q1 2025 earnings per share (EPS) estimates for shares of Legend Biotech in a note issued to investors on Wednesday, March 13th. William Blair analyst S. Corwin expects that the company will post earnings of ($0.30) per share for the quarter. […]

Leave a Reply

Your email address will not be published.

Previous post Contrasting Revvity (NYSE:RVTY) & Pressure BioSciences (OTCMKTS:PBIO)
Next post Critical Comparison: BYD (OTCMKTS:BYDDY) & Ero Copper (NYSE:ERO)